IDEXX Laboratories Inc (IDXX)

114.08
0.50 0.44
NASDAQ : Health Care
Prev Close 114.58
Open 114.80
Day Low/High 113.73 / 115.87
52 Wk Low/High 63.48 / 95.55
Volume 757.32K
Avg Volume 504.20K
Exchange NASDAQ
Shares Outstanding 89.66M
Market Cap 10.24B
EPS 2.10
P/E Ratio 48.58
Div & Yield N.A. (N.A)

Latest News

Jim Cramer -- Buy Zoetis, Idexx Over Freshpet

Jim Cramer -- Buy Zoetis, Idexx Over Freshpet

Jim Cramer says Freshpet is only a takeover play and suggests buying Zoetis or Idexx Labs instead.

'Mad Money' Lightning Round: Cramer's Been Behind MGM Resorts for a Long Time

'Mad Money' Lightning Round: Cramer's Been Behind MGM Resorts for a Long Time

MGM: 'I like the CEO and I like the REIT,' Jim Cramer says.

Jim Cramer's 'Mad Money' Recap: The Three Faces of the Stock Market

Jim Cramer's 'Mad Money' Recap: The Three Faces of the Stock Market

Know which stocks are interest-rate sensitive and which don't care, says Jim Cramer.

Bet on Animal Health By Investing in Idexx Laboratories, Analysts Say

Bet on Animal Health By Investing in Idexx Laboratories, Analysts Say

The animal health industry looks poised for growth, analysts say, and Idexx Laboratories IDXX stands to benefit.

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

Cramer is sticking with International Paper and likes Advanced Micro Devices.

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

This is not the time to sell in a panic, Cramer says.

5 Big Stocks to Buy Following Friday's Selloff

5 Big Stocks to Buy Following Friday's Selloff

These stocks have both short-term gain catalysts and longer-term growth potential.

Pets Are Big Business Now and These Stocks Are Behind the Trend

Pets Are Big Business Now and These Stocks Are Behind the Trend

TheStreet's Jim Cramer says the humanization of pets is a growing investment opportunity.

Pets Are Family Now and These Stocks Are Best in Show

Pets Are Family Now and These Stocks Are Best in Show

The humanization of pets has sent spending soaring, which has some pet-related stock seeing major benefits.

CMCSA, IDXX, ZTS: Jim Cramer's Views

CMCSA, IDXX, ZTS: Jim Cramer's Views

Cramer shares his views on the winners and losers of this earnings season. Comcast, Idexx Laboratories and Zoetis are among the stocks discussed.

Has IDEXX Labs Hit an Exhaustion Gap?

It's best to stay nimble with this one.

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Cramer has seen enough in this earnings season to come to some conclusions on what's working and what isn't.

Cramer: Here's What to Embrace and What to Shun

Cramer: Here's What to Embrace and What to Shun

With enough of earnings season now under our belt, we check out the promising themes and the sectors to avoid.

Barbarian At The Gate: IDEXX Laboratories (IDXX)

Barbarian At The Gate: IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

New Lifetime High Reached By IDEXX Laboratories (IDXX)

New Lifetime High Reached By IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a new lifetime high candidate

IDEXX Releases Revolutionary Water Test To Aid In The Fight Against Legionnaires' Disease

IDEXX Releases Revolutionary Water Test To Aid In The Fight Against Legionnaires' Disease

Legiolertâ„¢radically simplifies Legionella water testing compared to current culture methods

Trade-Ideas: IDEXX Laboratories (IDXX) Is Today's Strong And Under The Radar Stock

Trade-Ideas: IDEXX Laboratories (IDXX) Is Today's Strong And Under The Radar Stock

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a strong and under the radar candidate

Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive

Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive

Cramer is faithful to pet care drug maker Zoetis and he prefers Danaher over its split-off sibling Fortive.

Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail

Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail

Johnson & Johnson was easy, Cramer says, but other stocks were more problematic.

Valeant, Chipotle Both Rise After Sequoia Trades One Troubled Stock For Another

Valeant, Chipotle Both Rise After Sequoia Trades One Troubled Stock For Another

Sequoia Fund has sold its position in Valeant Pharmaceuticals and has added four new positions.

Sequoia Fund Drops Valeant, Allergan and Cabela's

Sequoia Fund Drops Valeant, Allergan and Cabela's

The company once held a 30% stake in Valeant, now owns no Valeant shares.